223 related articles for article (PubMed ID: 10866518)
1. [Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis].
Grange JD; Amiot X
Gastroenterol Clin Biol; 2000 Mar; 24(3):378-9. PubMed ID: 10866518
[No Abstract] [Full Text] [Related]
2. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous peritonitis: a new indication for intravenous albumin?].
Moreau R
Gastroenterol Clin Biol; 2000 Mar; 24(3):335-6. PubMed ID: 10804342
[No Abstract] [Full Text] [Related]
4. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis.
Bass NM
N Engl J Med; 1999 Aug; 341(6):443-4. PubMed ID: 10432331
[No Abstract] [Full Text] [Related]
5. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: is it worth the cost?
Brand RE
Am J Gastroenterol; 1999 Dec; 94(12):3404. PubMed ID: 10606292
[No Abstract] [Full Text] [Related]
6. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis.
Patch D; Burroughs A
N Engl J Med; 1999 Dec; 341(23):1773-4. PubMed ID: 10610455
[No Abstract] [Full Text] [Related]
7. [Spontaneous bacterial peritonitis, a severe complication in patients with liver cirrhosis].
Plokker HM; ten Hove WR; van der Heyden JT
Ned Tijdschr Geneeskd; 2007 Jun; 151(22):1258; author reply 1258-9. PubMed ID: 17583097
[No Abstract] [Full Text] [Related]
8. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
Navasa M; Follo A; Filella X; Jiménez W; Francitorra A; Planas R; Rimola A; Arroyo V; Rodés J
Hepatology; 1998 May; 27(5):1227-32. PubMed ID: 9581675
[TBL] [Abstract][Full Text] [Related]
9. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Sirinthornpunya S; Luangvichcharoen K
J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
[TBL] [Abstract][Full Text] [Related]
10. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.
van Erpecum KJ
Scand J Gastroenterol Suppl; 2006; (243):79-84. PubMed ID: 16782626
[TBL] [Abstract][Full Text] [Related]
11. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Fernández J; Monteagudo J; Bargallo X; Jiménez W; Bosch J; Arroyo V; Navasa M
Hepatology; 2005 Sep; 42(3):627-34. PubMed ID: 16108036
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis.
Ensaroğlu F; Korkmaz M; Geçkil AÜ; Öcal S; Koç B; Yıldız Ö; Atalay FB; Taş EG; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():131-6. PubMed ID: 26640933
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
15. Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Cartier M; Terg R; Lucero R; Muñoz A; Romero G; Levi D; Miguez C; Abecasis R
Aliment Pharmacol Ther; 2010 Jul; 32(1):43-8. PubMed ID: 20345510
[TBL] [Abstract][Full Text] [Related]
16. The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Tandon P; Kumar D; Seo YS; Chang HJ; Chaulk J; Carbonneau M; Qamar H; Keough A; Mansoor N; Ma M
Am J Gastroenterol; 2013 Sep; 108(9):1473-9. PubMed ID: 23877350
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.
Jepsen P; Vilstrup H; Møller JK; Sørensen HT
Hepatogastroenterology; 2003; 50(54):2133-6. PubMed ID: 14696480
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis.
Silvain C; Besson I; Ingrand P; Mannant PR; Fort E; Beauchant M
J Hepatol; 1993 Aug; 19(1):188-9. PubMed ID: 8301039
[No Abstract] [Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of spontaneous bacterial peritonitis in cirrhotic patients].
Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):408-10. PubMed ID: 18578987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
